Last reviewed · How we verify

NCT04982185

Neuromuscular Block Monitoring During Monitored Thyroidectomy

Completed Last updated 8 October 2021
What this trial tests

trial in Thyroid Surgery in 116 participants. Completed in 31 July 2021.

Timeline
1 August 2019
Primary endpoint
31 July 2020
31 July 2021

Quick facts

Lead sponsorKaohsiung Medical University Chung-Ho Memorial Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment116
Start date1 August 2019
Primary completion31 July 2020
Estimated completion31 July 2021
Sites1 location across Taiwan

Conditions studied

Sponsor

Kaohsiung Medical University Chung-Ho Memorial Hospital

Who can join

20 and older, any sex, with Thyroid Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Titration of neuromuscular block (NMB) plays a key role in intraoperative recurrent laryngeal nerve monitoring during thyroid surgery. Aim to titrate sugammadex dose based on neuromuscular block degree as a surgeon friendly protocol with high intraoperative neuromonitoring (IONM) quality.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Thyroid Surgery

Currently open trials in the same condition.

Other Kaohsiung Medical University Chung-Ho Memorial Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04982185.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing